Importance of MHC class I α2 and α3 domains in the recognition of self and non-self MHC molecules

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2473-2480

  Newberg, Michael H ^a   Smith, Deborah H ^b   Haertel, Sonja B ^a   Vining, Donna R ^a   Lacy, Elizabeth ^b   Engelhard, Victor H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SELF TOLERANCE; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VIRAL MATRIX PROTEINS;

EID: 0029968531     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Townsend, A. R., J. B. Rothbard, F. M. Gotch, G. Bahadur, D. C. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959.
2. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
3. Fischer Lindahl, K., and D. B. Wilson. 1977. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J. Exp. Med. 145:508.
4. Dutton, R. W., P. R. Panfili, and S. L. Swain. 1978. Alloreactivity, the development of the T cell repertoire and the understanding of T cell function. Immunol. Rev. 42:20.
5. Holterman, M. J., and V. H. Engelhard. 1986. HLA antigens expressed on murine cells are preferentially recognized by murine cytotoxic T cells in the context of the H-2 major histocompatibility complex. Proc. Natl. Acad. Sci. USA 83:9699.
6. Engelhard, V. H., A.-X. T. Le, and M. J. Holterman. 1988. Species-specific structural differences in the α1 and α2 domains determine the frequency of murine cytotoxic T cell precursors stimulated by human and murine class I molecules. J. Immunol. 141:1835.
7. Le, A.-X. T., E. J. Bernhard, M. J. Holterman, S. Strub, P. Parham, E. Lacy, and V. H. Engelhard. 1989. Cytotoxic T cell responses in HLA-A2.1 transgenic mice: recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. J. Immunol. 142:1366.
8. Hammerling, G. J., T. Hunt, O. Dill, and J. Moreno. 1989. Cytotoxic T lymphocyte recognition of HLA-A2 antigens in normal and HLA-Cw3-transgenic mice. Eur. J. Immunol. 19:599.
9. 2m double transgenic mice. J. Immunol. 143: 3117.
10. Kievits, F., W. J. Boerenkamp, W. Lokhorst, and P. Ivanyi. 1990. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice: a transgenic model for MHC xenoantigen recognition. J. Immunol. 144:4513.
11. Epstein, H., R. Hardy, J. S. May, M. H. Johnson, and N. Holmes. 1989. Expression and function of HLA-A2.1 in transgenic mice. Eur. J. Immunol. 19:1575.
12. Dill, O., F. Kievits, S. Koch, P. Ivanyi, and G. J. Hammerling. 1988. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc. Natl. Acad. Sci. USA 85:5664.
13. Engelhard, V. H., E. Lacy, and J. P. Ridge. 1991. Influenza A specific, HLA-A2.1 restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein. J. Immunol. 146:1226.
14. Sherman, L. A., S. V. Hesse, M. J. Irwin, D. La Face, and P. Peterson. 1992. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8. Science 258:815.
15. Irwin, M. J., W. R. Heath, and L. A. Sherman. 1989. Species-restricted interactions between CD8 and the α3 domain of class I influence the magnitude of the xenogeneic response. J. Exp. Med. 170:1091.
16. Samberg, N. L., E. C. Scarlett, and H. J. Stauss. 1989. The a3 domain of major histocompatibility complex class I molecules plays a critical role in cytotoxic T lymphocyte stimulation. Eur. J. Immunol. 19:2349.
17. Kalinke, U., B. Arnold, and G. J. Hammerling. 1991. Strong xenogeneic HLA response in transgenic mice after introducing an α3 domain into HLA-B27. Nature 348:642.
18. Newberg, M. H., J. P. Ridge, D. R. Vining, R. D. Salter, and V. H. Engelhard. 1992. Species specificity in the interaction of CD8 with the α3 domain of MHC class I molecules. J. Immunol. 149:136.
19. Sekimata, M., M. Tanabe, A. Sarai, J. Yamamoto, A. Kariyone, H. Nakauchi, K. Egawa, and M. Takiguchi. 1993. Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8. J. Immunol. 150:4416.
20. Engelhard, V. H., J. R. Yannelli, G. A. Evans, S. F. Walk, and M. J. Holterman. 1985. Construction of novel class I histocompatibility antigens by interspecies exon shuffling. J. Immunol. 134:4218.
21. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Engelhard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152:3862.
22. Bernhard, E. J., A.-X. T. Le, J. A. Barbosa, E. Lacy, and V. H. Engelhard. 1988. Cytotoxic T cells from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells. J. Exp. Med. 168:1157.
23. Bieberich, C., G. Scangos, K. Tanaka, and G. Jay. 1986. Regulated expression of a murine class I gene in transgenic mice. Mol. Cell. Biol. 6:1339.
24. Bieberich, C., T. Yoshioka, K. Tanaka, G. Jay, and G. Scangos. 1987. Functional expression of a heterologous major histocompatibility complex class I gene in transgenic mice. Mol. Cell. Biol. 7:4003.
25. Hogan, K. T., C. Clayberger, E. J. Bernhard, S. F. Walk, J. P. Ridge, P. Parham, A. M. Krensky, and V. H. Engelhard. 1988. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-deflned epitope differences between HLA-A2.1 and HLA-A2.3. J. Immunol. 141:2519.
26. Herman, A., P. Parham, S. M. Weissman, and V. H. Engelhard. 1983. Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer. Proc. Natl. Acad. Sci. USA 80:5056.
27. Crumpacker, D. B., J. Alexander, P. Cresswell, and V. H. Engelhard. 1992. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen processing mutant 174xCEM. T2. J. Immunol. 148:3004.
28. Holterman, M. J. 1987. The Role of Conserved Regions of Histocompatibility Antigens in the Stimulation of T-Lymphocytes. University of Virginia, Charlottesville, VA.
29. Smith, D. M., J. A. Bluestone, D. R. Jeyarajah, M. H. Newberg, V. H. Engelhard, J. Thistlethwaite, and E. S. Woodle. 1994. Inhibition of T cell activation by a monoclonal antibody reactive against the α3 domain of human MHC class I molecules. J. Immunol. 153:1054.
30. Chen, Y., J. Sidney, S. Southwood, A. L. Cox, K. Sakaguchi, R. Henderson, E. Appella, D. F. Hunt, A. Sette, and V. H. Engelhard. 1994. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations. J. Immunol. 152: 2874.
31. Lee, N. A., D. Y. Loh, and E. Lacy. 1992. CD8 surface levels alter the fate of alpha/beta T cell receptor-expressing thymocytes in transgenic mice. J. Exp. Med. 175:1013.
32. Robey, E. A., F. Ramsdell, D. Kioussis, W. Sha, D. Y. Loh, R. Axel, and B. J. Fowlkes. 1992. The level of CD8 expression can determine the outcome of thymic selection. Cell 69:1089.
33. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
34. Ashton-Rickardt, P. G., A. Bandeira, J. R. Delaney, L. Van Kaer, H.-P. Pircher, R. M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell 76:651.
35. Arnold, B., H. G. Burgert, U. Hamann, G. J. Hammerling, U. Kees, and S. Kvist. 1984. Cytolytic T cells recognize the two amino-terminal domains of H-2 K antigens in tandem in influenza A infected cells. Cell 38:79.
36. Ozato, K., G. A. Evans, B. Shykind, D. H. Margulies, and J. G. Seidman. 1983. Hybrid H-2 histocompatibility gene products assign domains recognized by alloreacrive T cells. Proc. Natl Acad. Sci. USA 80:2040.
37. Bluestone, J. A., M. Foo, H. Allen, D. Segal, and R. A. Flavell. 1985. Allospecific cytolytic T lymphocytes recognize conformational determinants on hybrid mouse transplantation antigens. J. Exp. Med 162:268.
38. Tanabe, M., M. Takiguchi, J. Yamamoto, H. Hayashi, and K. Kano. 1989. Analysis of xenoantigenicity of HLA class I molecules by a complete series of human-mouse hybrid genes. Transplantation 48:135.
39. Collins, E. J., D. N. Gaiboczi, M. N. Katpusas, and D. C. Wiley. 1995. The three-dimensional structure of a class I major histocompatibility complex molecule missing the α3 domain of the heavy chain. Proc. Natl. Acad. Sci. USA 92:1218.
40. Aldrich, C. J., R. E. Hammer, S. Jones-Youngblood, U. Koszinowski, L. Hood, I. Stroynowski, and J. Forman. 1991. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the α3 domain of MHC I molecules. Nature 352:718.
41. Knobloch, M., G. Schonrich, J. Schenkel, M. Malissen, B. Malissen, A. M. Schmitt-Verhulst, G. J. Hammerling, and B. Arnold. 1992. T cell activation and thymic tolerance induction require different adhesion intensities of the CD8 co-receptor. Int. Immunol. 4:1169.
42. Maziarz, R. T., S. J. Burakoff, and J. A. Bluestone. 1988. The alpha-3 domain of class I MHC proteins influences cytotoxic T lymphocyte recognition of antigenic determinants located within the alpha-1 and alpha-2 domains. J. Immunol. 140: 4372.
43. Giblin, P. A., D. J. Leahy, J. Mennone, and P. B. Kavathas. 1994. The role of charge and multiple faces of the CD8α/α homodimer in binding to major histocompatibility complex class I molecules: support for a bivalent model. Proc. Natl. Acad. Sci. USA 91:1716.
44. Norment, A. M., R. D. Salter, P. Parham, V. H. Engelhard, and D. R. Littman. 1988. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336:79.
45. Salter, R. D., A. M. Norment, B. P. Chen, C. Clayberger, A. M. Krensky, D. R. Littman, and P. Parham. 1989. Polymorphism in the alpha3 domain of HLA-A molecules affects binding to CD8. Nature 338:345.
46. Teitell, M., M. F. Mescher, C. A. Olson, D. R. Littman, and M. Kronenberg. 1991. The thymus leukemia antigen binds human and mouse CD8. J. Exp. Med. 174:1131.
47. Teitell, M., H. Holcombe, H. Cheroutre, C. J. Aldrich, I. Stroynowski, J. Forman, and M. Kronenberg. 1993. The a3 domain of the Qa-2 molecule is defective for CD8 binding and cytotoxic T lymphocyte activation. J. Exp. Med. 178:2139.
48. Sanders, S. K., R. O. Fox, and P. Kavathas. 1991. Mutations in CD8 that affect interactions with HLA class I and monoclonal anti-CD8 antibodies. J. Exp. Med. 174:371.
49. Braciale, T. J., M. E. Andrew, and V. L. Braciale. 1981. Simultaneous expression of H-2-reslricted and alloreactive recognition by a cloned line of influenza virus specific cytotoxic T lymphocytes. J. Exp. Med. 153:1371.
50. Ashwell, J. D., C. Chen, and R. H. Schwartz. 1986. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigens in association with self class II molecules. J. Immunol. 136:389.
51. b by alloreactive cytotoxic T lymphocytes. Nature 341:749.
52. Heath, W. R., K. P. Kane, M. F. Mescher, and L. A. Sherman. 1991. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 88:5101.
53. Rotzschke, O., K. Falk, S. Faath, and H. G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174:1059.
54. + cytotoxic T lymphocytes in association with class I MHC protein. Cell 69:989.
55. Chattopadhyay, S., M. Theobald, J. Biggs, and L. A. Sherman. 1994. Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity. J. Exp. Med. 179:213.